Comparison of susceptibility and transcription profile of the new antifungal hassallidin A with caspofungin

Biochemical and Biophysical Research Communications

Volumn 349, Issue 2, 2006, Pages 740-749

  Neuhof, Torsten ^a   Seibold, Michael ^b   Thewes, Sascha ^b   Laue, Michael ^b   Han, Chang Ok ^b   Hube, Bernhard ^b   von Döhren, Hans ^a  

^a TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Antifungal; Genome wide expression; Glycolipopeptide; Susceptibility; Ultrastructural changes

Indexed keywords

ANTIFUNGAL AGENT; CASPOFUNGIN; HASSALLIDIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL VIABILITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DNA REPAIR; DRUG STRUCTURE; ELECTRON MICROSCOPY; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; GENE CONTROL; MEMBRANE FUSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; CYTOPLASM; GENE EXPRESSION REGULATION, FUNGAL; GENOME, FUNGAL; GLYCOLIPIDS; LIPOPROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, CHEMICAL; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; PEPTIDES, CYCLIC; TRANSCRIPTION, GENETIC;

CANDIDA; CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS;

EID: 33748419894     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.08.110     Document Type: Article

References (33)

1. Beauvais A., and Latge J.P. Membrane and cell wall targets in Aspergillus fumigatus. Drug Resist. Updat. 1 (2001) 38-49
2. Ghannoum M.A., and Rice L.B. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 4 (1999) 501-517
3. Neuhof T., Schmieder P., Preussel K., Dieckmann R., Pham H., Bartl F., and von Döhren H. Hassallidin A, a glycosylated lipopeptide with antifungal activity from the cyanobacterium Hassallia sp. J. Nat. Prod. 68 (2005) 695-700
4. Wiederhold N.P., and Lewis R.E. The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy. Expert Opin. Investig. Drugs 8 (2003) 1313-1333
5. McCormack P.L., and Perry C.M. Caspofungin: a review of its use in the treatment of fungal infections. Drugs 14 (2005) 2049-2068
6. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS document M27-A2 (2002) NCCLS, Wayne, Pa.
7. Niewerth M., Kunze D., Seibold M., Schaller M., Korting H.C., and Hube B. Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors. Antimicrob. Agents Chemother. 6 (2003) 1805-1817
8. Fradin C., De Groot P., MacCallum D., Schaller M., Klis F., Odds F.C., and Hube B. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol. Microbiol. 2 (2005) 397-415
9. Sigle H.C., Thewes S., Niewerth M., Korting H.C., Schafer-Korting M., and Hube B. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans. Antimicrob. Agents Chemother. 55 (2005) 663-673
10. Marchetti M.A., Kumar S., Hartsuiker E., Maftahi M., Carr A.M., Freyer G.A., Burhans W.C., and Huberman J.A. A single unbranched S-phase DNA damage and replication fork blockage checkpoint pathway. Proc. Natl. Acad. Sci. USA 11 (2002) 7472-7477
11. Verkade H.M., Bugg S.J., Lindsay H.D., Carr A.M., and O'Connell M.J. Rad18 is required for DNA repair and checkpoint responses in fission yeast. Mol. Biol. Cell 10 (1999) 2905-2918
12. Hayne C., Tzivion G., and Luo Z. Raf-1/MEK/MAPK pathway is necessary for the G2/M transition induced by nocodazole. J. Biol. Chem. 41 (2000) 31876-31882
13. Liu X., Yan S., Zhou T., Terada Y., and Erikson R.L. The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 3 (2004) 763-776
14. Kelly T., Trischuk T., Lehner R., and Eitzen G. Enhanced membrane fusion in sterol-enriched vacuoles bypasses the Vrp1p requirement. Mol. Biol. Cell 15 (2004) 4609-4621
15. Zajac A., Sun X., Zhang J., and Wei G. Cyclical regulation of the exocyst and cell polarity, determinants for polarized cell growth. Mol. Biol. Cell 16 (2005) 1500-1512
16. Lesley J., Page, and Robinson M.S. Targeting signals and subunit interactions in coated vesicle adaptor complexes. J. Cell Biol. 131 (1995) 619-630
17. Burdick D., Le Gall A.H., and Rodriguez-Boulan E. Vesicular transport: implications for cell polarity. Biocell 3 (1996) 343-353
18. Mayer A. Membrane fusion in eukaryotic cells. Annu. Rev. Cell Dev. Biol. 18 (2002) 289-314
19. Yoda K., and Noda Y. Vesicular transport and the Golgi apparatus in yeast. J. Biosci. Bioeng. 1 (2001) 1-11
20. Levine T.P., Rabouille C., Kieckbusch R.H., and Warren G. Binding of the vesicle docking protein p115 to Golgi membranes is inhibited under mitotic conditions. J. Biol. Chem. 29 (1996) 17304-17311
21. Liu T.T., Lee R.E., Barker K.S., Lee R.E., Wei L., Homayouni R., and Rogers P.D. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob. Agents Chemother. 6 (2005) 2226-2236
22. Agarwal A.K., Rogers P.D., Baerson S.R., Jacob M.R., Barker K.S., Cleary J.D., Walker L.A., Nagle D.G., and Clark A.M. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J. Biol. Chem. 37 (2003) 34998-35015
23. Reinoso-Martin C., Schuller C., Schuetzer-Muehlbauer M., and Kuchler K. The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signalling. Eukaryot. Cell 6 (2003) 1200-1210
24. Griffioen G., Swinnen S., and Thevelein J.M. Feedback inhibition on cell wall integrity signaling by Zds1 involves Gsk3 phosphorylation of a cAMP-dependent protein kinase regulatory subunit. J. Biol. Chem. 26 (2003) 23460-23471
25. Roelants F.M., Torrance P.D., Bezman N., and Thorner J. Pkh1 and pkh2 differentially phosphorylate and activate ypk1 and ykr2 and define protein kinase modules required for maintenance of cell wall integrity. Mol. Biol. Cell 9 (2002) 3005-3028
26. Gale E.F., Johnson A.M., Kerridge D., and Koh T.Y. Factors affecting the changes in amphotericin B sensitivity of Candida albicans during growth. J. Gen. Microbiol. 87 (1995) 20-36
27. Kerridge D., Koh T.Y., Marriott M.S., and Gale E.F. Microbiology and plant protoplasts (1976), Churchill Livingston, London, England pp. 23-38
28. Edlind T.D., and Katiyar S.K. The echinocandin "target" identified by cross-linking is a homolog of Pil1 and Lsp1, sphingolipid-dependent regulators of cell wall integrity signalling. Antimicrob. Agents Chemother. 11 (2004) 4491
29. Luft J.H. Improvements in epoxy resin embedding methods. J. Biophys. Biochem. Cytol. 9 (1961) 409-416
30. Miyake K., and McNeil P.L. Vesicle accumulation and exocytosis at sites of plasma membrane disruption. J. Cell Biol. 131 (1995) 1737-1745
31. McNeil P.L. Repairing a torn cell surface: make way, lysosomes to the rescue. Cell Sci. 115 (2002) 873-879
32. Nishiyama Y., Uchida K., and Yamaguchi H. Morphological changes of Candida albicans induced by micafungin (FK463), a water-soluble echinocandin-like lipopeptide. J. Electron Microsc. 51 (2002) 247-255
33. Cassone A., Mason R.E., and Kerridge D. Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study. Sabouraudia 19 (1981) 97-110